A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
In late 2021, Amber Salzman interviewed for a job that she had no intention of taking. A relatively new start-up company, called Epicrispr Biotechnologies, was looking for a chief executive, and it ...
In "Regime Change, Inside the Imperial Presidency of Donald Trump," Maggie Haberman and Jonathan Swan describe his ...
Erik Steiger discusses the operational pain of legacy PDF generation in regulated banking and manufacturing. He explains how ...
Researchers led by developmental biologist Kathy Niakan at the University of Cambridge have used base editing in human embryos to learn more about human embryonic development. By deactivating a gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results